Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Potential Off-label Use of Dabigatran Etexilate in Europe

NCT02240654 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT02240654
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02240654 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Potential Off-label Use of Dabigatran Etexilate in Europe
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
November 28, 2014
Completion date
May 20, 2016
Enrollment
36,573 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation